Advocating for a world where intellectual
property law serves the public interest.

Analysis of Territorial Access Issues in the MPP/BMS Atazanavir License

On December 11, the Medicines Patent Pool announced a new licensing agreement for a 2013 WHO recommended second-line antiretroviral, atazanavir (ATV). At this point, it is important for IP activists, generic companies, and countries to understand both the express territorial coverage of the license (110 countries) and its “effective” territorial coverage as well (144 countries plus […]

Global Congress Endorses Principles for International Intellectual Property; Criticizes Trans Pacific Partnership (TPP)

Researchers, scholars and policy specialists from over 40 countries drafted and endorsed a declaration of Fundamental Public Interest Principles for International Intellectual Property Negotiations that are starkly at odds with some trade agreement negotiations. The Principles were adopted at the Third Global Congress on Intellectual Property and the Public Interest which met in Cape Town, […]

Digital School e-textbooks program: a year and a half later

[Centrum Cyfrowe, Link (CC-BY)] In 2012, Poland launched the “Digital School” program, an initiative to expand the use of information and communications technology (ICT) in K-12 schools. This program includes an OER component that is the first of its kind: a 3-year-long project to create a set of 18 core curriculum e-textbooks for K-12 schooling in Poland, available under […]

Convergence Of Who’s Who In IP, Innovation, Public Interest In Africa

[William New for IP Watch, Link, (CC-BY-NC-ND)] CAPE TOWN, SOUTH AFRICA – Academics, advocates, lawyers, government officials and others meeting this week helped launch several new books and research tools to better understand the relationship of intellectual property, development and social issues. In particular, discussion in the early part of the conference focused on a […]

Medicines Patent Pool and Bristol-Myers Squibb Sign Agreement to Further Expand Access to a Key HIV Medicine

[MPP Press release, Link (CC-NC-ND)] The Medicines Patent Pool (MPP) and biopharmaceutical company Bristol-Myers Squibb have signed a licensing agreement to increase access to a key HIV medicine, atazanavir, in 110 developing countries. These countries represent 88.5 percent of people living with HIV/AIDS in developing countries. “This agreement will allow manufacturers world-wide to produce more […]

Day 3 (or is it Day 1?) of the Global Congress for IP in the Public Interest

[Isaac Rutenburg, Afro-IP, Link (CC_BY)] Today is Day 3 of the Global Congress and OpenAIR conference in Cape Town, SA. It also marks the shift of focus from OpenAIR to the Global Congress per se. The day began with, among other things, a summary of activist activities in Canada against oppressive copyright legislation. It seems […]